share_log

TC BioPharm | DEF 14A: Definitive information statements

SEC announcement ·  Feb 20 06:08
Summary by Moomoo AI
TC BioPharm (Holdings) PLC, a biopharmaceutical company, has announced a General Meeting (GM) of shareholders to be held on March 14, 2024. The meeting will take place at 2:00 p.m. UK time at the company's registered office in Holytown, Motherwell. The GM will address two ordinary resolutions: the authorization to adjourn the meeting if necessary to solicit further proxies, and the authorization to issue securities in one or more non-public offerings in accordance with Nasdaq Marketplace Rule 5635(d). The latter is a strategic move to raise additional capital up to $4 million, which is crucial for the company's operations and business strategy implementation. The Board of Directors unanimously recommends shareholders vote in favor of the resolutions, emphasizing their alignment with...Show More
TC BioPharm (Holdings) PLC, a biopharmaceutical company, has announced a General Meeting (GM) of shareholders to be held on March 14, 2024. The meeting will take place at 2:00 p.m. UK time at the company's registered office in Holytown, Motherwell. The GM will address two ordinary resolutions: the authorization to adjourn the meeting if necessary to solicit further proxies, and the authorization to issue securities in one or more non-public offerings in accordance with Nasdaq Marketplace Rule 5635(d). The latter is a strategic move to raise additional capital up to $4 million, which is crucial for the company's operations and business strategy implementation. The Board of Directors unanimously recommends shareholders vote in favor of the resolutions, emphasizing their alignment with the company's best interests. Shareholders registered by March 12, 2024, are entitled to vote, and the company has provided detailed instructions for voting, including for holders of American Depositary Shares (ADSs). The GM documentation and voting instruction cards will be distributed accordingly, with a deadline for ADS voting instructions set for March 8, 2024. The company's CEO, Bryan Kobel, has expressed gratitude for the ongoing support and highlighted the importance of the resolutions for the company's future success.

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more